Tenaya Therapeutics (TNYA) Earnings Date & Reports

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TNYA is expected to report earnings to fall 29.17% to -17 cents per share on August 06

Tenaya Therapeutics TNYA Stock Earnings Reports

Q2'25

Est.

$-0.17

Q1'25

Missed

by $0.05

Q4'24

Beat

by $0.03

Q3'24

Beat

by $0.07

Q2'24

Beat

by $0.05

The last earnings report on May 07 showed earnings per share of -23 cents, missing the estimate of -18 cents. With 3.70M shares outstanding, the current market capitalization sits at 64.14M.

View a ticker or compare two or three

Compare

TNYA